Eisai

1 trends tracked about this subject — the full history, oldest to newest below.

↑ Rising Business 🔮 fades ✗

The FDA has approved a subcutaneous autoinjector for Leqembi, enabling at-home initiation doses for patients with early Alzheimer's disease.

6 sources 6 articles v 4 1d ago